Use of new and uncommon synthetic psychoactive drugs among a nationally representative sample in the United States, 2005-2017.

ABSTRACT:

Objectives

This study aims to examine patterns and first mentions of reported use of new or uncommon drugs across 13 years, among nationally representative samples in the United States.

Methods

Participants (ages ≥12) in the National Surveys on Drug Use and Health (2005-2017, N = 730,418) were provided opportunities to type in names of new or uncommon drugs they had ever used that were not specifically queried. We examined self-reported use across survey years and determined years of first mentions.

Results

From 2005 to 2017, there were 2,343 type-in responses for use of 79 new or uncommon synthetic drugs, and 54 were first-ever mentions of these drugs. The majority (65.8%) of mentions were phenethylamines (e.g., 2C-x, NBOMe), which were also the plurality of new drug

SUBMITTER: Palamar JJ 

PROVIDER: S-EPMC6534815 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature